CoChat

Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Introduction: Acute kidney injury (AKI) is a frequent complication of cardiopulmonary bypass (CPB). The lack of early biomarkers has impaired our ability to intervene in a timely manner. We previously showed in a small cohort of patients that plasma neutrophil gelatinase-associated lipocalin (NGAL), measured using a research enzyme-linked immunosorbent assay, is an early predictive biomarker of AKI after CPB. In this study we tested whether a point-of-care NGAL device can predict AKI after CPB in a larger cohort. Methods: First, in a cross-sectional pilot study including 40 plasma samples (NGAL range 60 to 730 ng/ml) and 12 calibration standards (NGAL range 0 to 1,925 ng/ml), NGAL measurements by enzyme-linked immunosorbent assay and by Triage® NGAL Device (Biosite Inc., San Diego, CA, USA) were highly correlated (r = 0.94). Second, in a subsequent prospective uncontrolled cohort study, 120 children undergoing CPB were enrolled. Plasma was collected at baseline and at frequent intervals for 24 hours after CPB, and analyzed for NGAL using the Triage® NGAL device. The primary outcome was AKI, which was defined as a 50% or greater increase in serum creatinine. Results: AKI developed in 45 patients (37%), but the diagnosis using serum creatinine was delayed by 2 to 3 days after CPB. In contrast, mean plasma NGAL levels increased threefold within 2 hours of CPB and remained significantly elevated for the duration of the study. By multivariate analysis, plasma NGAL at 2 hours after CPB was the most powerful independent predictor of AKI (β = 0.004, P < 0.0001). For the 2-hour plasma NGAL measurement, the area under the curve was 0.96, sensitivity was 0.84, and specificity was 0.94 for prediction of AKI using a cut-off value of 150 ng/ml. The 2 hour postoperative plasma NGAL levels strongly correlated with change in creatinine (r = 0.46, P < 0.001), duration of AKI (r = 0.57, P < 0.001), and length of hospital stay (r = 0.44, P < 0.001). The 12-hour plasma NGAL strongly correlated with mortality (r = 0.48, P = 0.004) and all measures of morbidity mentioned above. Conclusion: Accurate measurements of plasma NGAL are obtained using the point-of-care Triage® NGAL device. Plasma NGAL is an early predictive biomarker of AKI, morbidity, and mortality after pediatric CPB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc6192

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Correlation between Triage® NGAL device and ELISA. Shown is the correlation between plasma NGAL measurements obtained by Triage® NGAL device and research-based NGAL ELISA assay (Pearson r = 0.94, 95% confidence interval 0.89 to 0.96; P < 0.001). The regression line shown yielded a slope of 0.671 (95% confidence interval 0.600 to 0.741) and an intercept of 48.82 (95% confidence interval 18.66 to 78.99). ELISA, enzyme-linked immunosorbent assay; NGAL, neutrophil gelatinase-associated lipocalin.
Figure 1 Correlation between Triage® NGAL device and ELISA. Shown is the correlation between plasma NGAL measurements obtained by Triage® NGAL device and research-based NGAL ELISA assay (Pearson r = 0.94, 95% confidence interval 0.89 to 0.96; P < 0.001). The regression line shown yielded a slope of 0.671 (95% confidence interval 0.600 to 0.741) and an intercept of 48.82 (95% confidence interval 18.66 to 78.99). ELISA, enzyme-linked immunosorbent assay; NGAL, neutrophil gelatinase-associated lipocalin.CC BY · PubMed Central
Figure 2 Plasma NGAL measurements obtained using Triage® NGAL device at various time points after CPB. AKI was defined as a 50% increase in serum creatinine from baseline. Values are expressed as means ± standard deviation. *P < 0.0001 comparing AKI versus no AKI groups. AKI, acute kidney injury; CPB, cardiopulmonary bypass; NGAL, neutrophil gelatinase-associated lipocalin.
Figure 2 Plasma NGAL measurements obtained using Triage® NGAL device at various time points after CPB. AKI was defined as a 50% increase in serum creatinine from baseline. Values are expressed as means ± standard deviation. *P < 0.0001 comparing AKI versus no AKI groups. AKI, acute kidney injury; CPB, cardiopulmonary bypass; NGAL, neutrophil gelatinase-associated lipocalin.CC BY · PubMed Central
Figure 3 ROC analysis of 2-hour NGAL at three cut-offs. Shown is a ROC curve analysis of the 2-hour plasma NGAL measurements with the three cut-off levels from Table 2 indicated as filled squares annotated with the corresponding NGAL concentration. The area under the curve was 0.96 (95% confidence interval 0.94 to 0.99). NGAL, neutrophil gelatinase-associated lipocalin; ROS, receiver operating characteristic.
Figure 3 ROC analysis of 2-hour NGAL at three cut-offs. Shown is a ROC curve analysis of the 2-hour plasma NGAL measurements with the three cut-off levels from Table 2 indicated as filled squares annotated with the corresponding NGAL concentration. The area under the curve was 0.96 (95% confidence interval 0.94 to 0.99). NGAL, neutrophil gelatinase-associated lipocalin; ROS, receiver operating characteristic.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 488

Metadata

Authors
Dent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Columbia University (US)
Corresponding author
Devarajan, Prasad
Venue
Critical Care
Published
2007-12-10
Volume
11
Issue
6
Pages
R127-R127
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2035397803
Cited by
483
References
33
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 11 · 2021: 18 · 2020: 8 · 2019: 15 · 2018: 18 · 2017: 20 · 2016: 36 · 2015: 46 · 2014: 43 · 2013: 47 · 2012: 49
FWCI
22.86
Type
journal article
Language
en
Open access
Licence
Locations
  • Critical Care (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Cincinnati Children's Hospital Medical Center
  • National Institutes of Health (DK52612)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R21DK070163, P50DK052612, R01DK053289)
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
neutrophil gelatinase-associated lipocalin, acute kidney injury, pediatric cardiac surgery, cardiopulmonary bypass, point-of-care biomarkers, early prediction of AKI, serum creatinine, postoperative morbidity and mortality, length of hospital stay, renal function monitoring, pediatric congenital heart disease, postoperative renal complications, biomarker validation
MeSH terms
Lipocalin-2, Acute-Phase Proteins, Child, Child, Preschool, Cross-Sectional Studies, Female, Cardiac Surgical Procedures, Humans, Male, Morbidity, Mortality, Pilot Projects, Predictive Value of Tests, Prospective Studies, Proto-Oncogene Proteins, Cohort Studies, Biomarkers, Point-of-Care Systems, Lipocalins, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.